Clinical trial
Rheohemapheresis and Lutein Supplementation in the Non-Exsudative Form of…
NCT00443911 · The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery, Other · Unknown status
Key facts
| NCT number | NCT00443911 |
|---|---|
| Title | Rheohemapheresis and Lutein Supplementation in the Non-Exsudative Form of Age-Related Macular Degeneration |
| Official title | Rheohemapheresis and Lutein Supplementation (Xantophyll Carotenoid) in the Non-Exsudative Form of Age-Related Macular Degeneration |
| Acronym | ReLux-AMD |
| Lead sponsor | The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery, Other |
| Status | Unknown status |
| Study type | Observational |
| Conditions | Age-related Macular Degeneration |
| Enrollment | 20 |
| Start date | Mar 1, 2007 |
| Completion | May 1, 2012 |
| First posted | Mar 7, 2007 |
| Last update posted | Jun 27, 2011 |
| Countries | Austria |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: